Unknown

Dataset Information

0

Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.


ABSTRACT: Similar to human chronic lymphocytic leukemia (CLL), the de novo New Zealand Black (NZB) mouse model has a genetically determined age-associated increase in malignant B-1 clones and decreased expression of microRNAs miR-15a and miR-16 in B-1 cells. In the present study, lentiviral vectors were employed in vivo to restore miR-15a/16, and both the short-term single injection and long-term multiple injection effects of this delivery were observed in NZB. Control lentivirus without the mir-15a/16 sequence was used for comparison. We found that in vivo lentiviral delivery of mir-15a/16 increased miR-15a/16 expression in cells that were transduced (detected by GFP expression) and in sera when compared with control lentivirus treatment. More importantly, mice treated with the miR-expressing lentivirus had decreased disease. The lentivirus had little systemic toxicity while preferentially targeting B-1 cells. Short-term effects on B-1 cells were direct effects, and only malignant B-1 cells transduced with miR-15a/16 lentivirus had decreased viability. In contrast, long-term studies suggested both direct and indirect effects resulting from miR-15a/16 lentivirus treatment. A decrease in B-1 cells was found in both the transduced and non-transduced populations. Our data support the potential use of systemic lentiviral delivery of miR-15a/16 to ameliorate disease manifestations of CLL.

SUBMITTER: Kasar S 

PROVIDER: S-EPMC3516396 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.

Kasar S S   Salerno E E   Yuan Y Y   Underbayev C C   Vollenweider D D   Laurindo M F MF   Fernandes H H   Bonci D D   Addario A A   Mazzella F F   Raveche E E  

Genes and immunity 20110901 2


Similar to human chronic lymphocytic leukemia (CLL), the de novo New Zealand Black (NZB) mouse model has a genetically determined age-associated increase in malignant B-1 clones and decreased expression of microRNAs miR-15a and miR-16 in B-1 cells. In the present study, lentiviral vectors were employed in vivo to restore miR-15a/16, and both the short-term single injection and long-term multiple injection effects of this delivery were observed in NZB. Control lentivirus without the mir-15a/16 se  ...[more]

Similar Datasets

| S-EPMC4784815 | biostudies-literature
| S-EPMC4198514 | biostudies-literature
| S-EPMC3277352 | biostudies-other
| S-EPMC4508006 | biostudies-literature
| S-EPMC5308631 | biostudies-literature
| S-EPMC11012944 | biostudies-literature
| S-EPMC7852530 | biostudies-literature
| S-EPMC2820079 | biostudies-literature
| S-EPMC9393331 | biostudies-literature
| S-EPMC4312582 | biostudies-literature